Literature DB >> 22896727

Impact of organic solvents on cytochrome P450 probe reactions: filling the gap with (S)-Warfarin and midazolam hydroxylation.

Vanessa González-Pérez1, Elizabeth A Connolly, Arlene S Bridges, Larry C Wienkers, Mary F Paine.   

Abstract

(S)-Warfarin 7-hydroxylation and midazolam 1'-hydroxylation are among the preferred probe substrate reactions for CYP2C9 and CYP3A4/5, respectively. The impact of solvents on enzyme activity, kinetic parameters, and predicted in vivo hepatic clearance (Cl(H)) associated with each reaction has not been evaluated. The effects of increasing concentrations [0.1-2% (v/v)] of six organic solvents (acetonitrile, methanol, ethanol, dimethyl sulfoxide, acetone, isopropanol) were first tested on each reaction using human liver microsomes (HLMs), human intestinal microsomes (midazolam 1'-hydroxylation only), and recombinant enzymes. Across enzyme sources, relative to water, acetonitrile and methanol had the least inhibitory effect on (S)-warfarin 7-hydroxylation (0-58 and 9-96%, respectively); acetonitrile, methanol, and ethanol had the least inhibitory effect on midazolam 1'-hydroxylation (0-29, 0-22, and 0-20%, respectively). Using HLMs, both acetonitrile and methanol (0.1-2%) decreased the V(max) (32-60 and 24-65%, respectively) whereas methanol (2%) increased the K(m) (100%) of (S)-warfarin-hydroxylation. (S)-Warfarin Cl(H) was underpredicted by 21-65% (acetonitrile) and 13-84% (methanol). Acetonitrile, methanol, and ethanol had minimal to modest impact on both the kinetics of midazolam 1'-hydroxylation (10-24%) and predicted midazolam Cl(H) (2-20%). In conclusion, either acetonitrile or methanol at ≤0.1% is recommended as the primary organic solvent for the (S)-warfarin 7-hydroxylation reaction; acetonitrile is preferred if higher solvent concentrations are required. Acetonitrile, methanol, and ethanol at ≤2% are recommended as primary organic solvents for the midazolam 1'-hydroxylation reaction. This information should facilitate optimization of experimental conditions and improve the interpretation and accuracy of in vitro-in vivo predictions involving these two preferred cytochrome P450 probe substrate reactions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22896727      PMCID: PMC3477202          DOI: 10.1124/dmd.112.047134

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  39 in total

1.  CYP2C9 inhibition: impact of probe selection and pharmacogenetics on in vitro inhibition profiles.

Authors:  Vikas Kumar; Jan L Wahlstrom; Dan A Rock; Chad J Warren; Lee A Gorman; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2006-09-08       Impact factor: 3.922

2.  Enzyme source effects on CYP2C9 kinetics and inhibition.

Authors:  Vikas Kumar; Dan A Rock; Chad J Warren; Timothy S Tracy; Jan L Wahlstrom
Journal:  Drug Metab Dispos       Date:  2006-08-23       Impact factor: 3.922

Review 3.  Methods for predicting in vivo pharmacokinetics using data from in vitro assays.

Authors:  J Brian Houston; Aleksandra Galetin
Journal:  Curr Drug Metab       Date:  2008-11       Impact factor: 3.731

4.  Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity.

Authors:  C Tang; M Shou; A D Rodrigues
Journal:  Drug Metab Dispos       Date:  2000-05       Impact factor: 3.922

5.  Sodium warfarin.

Authors:  R A O'Reilly
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

6.  Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.

Authors:  S M Tsunoda; R L Velez; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1999-11       Impact factor: 6.875

7.  Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities.

Authors:  D Hickman; J P Wang; Y Wang; J D Unadkat
Journal:  Drug Metab Dispos       Date:  1998-03       Impact factor: 3.922

8.  Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. Species differences, induction effects, and mechanistic studies.

Authors:  A E Rettie; M Boberg; A W Rettenmeier; T A Baillie
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

9.  The human intestinal cytochrome P450 "pie".

Authors:  Mary F Paine; Heather L Hart; Shana S Ludington; Robert L Haining; Allan E Rettie; Darryl C Zeldin
Journal:  Drug Metab Dispos       Date:  2006-02-07       Impact factor: 3.922

10.  Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans.

Authors:  Ngoc Ngo; Zhixia Yan; Tyler N Graf; Daniel R Carrizosa; Angela D M Kashuba; E Claire Dees; Nicholas H Oberlies; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2008-12-29       Impact factor: 3.922

View more
  3 in total

1.  Effect of Water Miscible Organic Solvents on p-Nitrophenol Hydroxylase (CYP2E1) Activity in Rat Liver Microsomes.

Authors:  Pranali G Patil; S H Kamble; T S Shah; K R Iyer
Journal:  Indian J Pharm Sci       Date:  2015 May-Jun       Impact factor: 0.975

2.  Contribution of baicalin on the plasma protein binding displacement and CYP3A activity inhibition to the pharmacokinetic changes of nifedipine in rats in vivo and in vitro.

Authors:  Zhen-Yu Cheng; Xin Tian; Jie Gao; Hong-Meng Li; Lin-Jing Jia; Hai-Ling Qiao
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

3.  Effect of Water-miscible Organic Solvents on CYP450-mediated Metoprolol and Imipramine Metabolism in Rat Liver Microsomes.

Authors:  T S Shah; S H Kamble; Pranali G Patil; K R Iyer
Journal:  Indian J Pharm Sci       Date:  2015 Jul-Aug       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.